Details for New Drug Application (NDA): 219873
✉ Email this page to a colleague
NDA 219873 describes DESMODA, which is a drug marketed by Eton and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the DESMODA profile page.
The generic ingredient in DESMODA is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
The generic ingredient in DESMODA is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.
Summary for 219873
| Tradename: | DESMODA |
| Applicant: | Eton |
| Ingredient: | desmopressin acetate |
| Patents: | 2 |
Suppliers and Packaging for NDA: 219873
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DESMODA | desmopressin acetate | SOLUTION;ORAL | 219873 | NDA | Eton Pharmaceuticals, Inc. | 71863-123 | 71863-123-14 | 145 mL in 1 BOTTLE (71863-123-14) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 0.05MG/ML | ||||
| Approval Date: | Feb 25, 2026 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Apr 3, 2044 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Start Trial | Patent Expiration: | Apr 3, 2044 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | MANAGEMENT OF CENTRAL DIABETES INSIPIDUS AS ANTIDIURETIC REPLACEMENT THERAPY FOR ADULTS AND PEDIATRIC PATIENTS | ||||||||
Complete Access Available with Subscription
